Protein-Protein Interactions in Human Disease, Part B, Volume 111
1st Edition
Secure Checkout
Personal information is secured with SSL technology.Free Shipping
Free global shippingNo minimum order.
Table of Contents
1. Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design
Sitanshu S. Singh and Seetharama D. Jois
2. Targeting Intramembrane Protein–Protein Interactions: Novel Therapeutic Strategy of Millions Years Old
Alexander B. Sigalov
3. Targeting the Architecture of Deregulated Protein Complexes in Cancer
Eduard Stefan, Jakob Troppmair and Klaus Bister
4. Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis
Iva Ugrinova, Maria Petrova, Mounira Chalabi-Dchar and Philippe Bouvet
5. Subcellular Targeting of Nitric Oxide Synthases Mediated by Their N-Terminal Motifs
Carlos Costas-Insua, Javier Merino-Gracia, Clara Aicart-Ramos and Ignacio Rodríguez-Crespo
6. Development of Protein–Protein Interaction Inhibitors for the Treatment of Infectious Diseases
Andrew F. Voter and James L. Keck
7. Defining Pharmacological Targets by Analysis of Virus–Host Protein Interactions
Manuel Llano and Mario A. Peña-Hernandez
8. Investigating the Influence of Hotspot Mutations in Protein–Protein Interaction of IDH1 Homodimer Protein: A Computational Approach
D. Thirumal Kumar, P. Sneha, Jennifer Uppin, S. Usha and C. George Priya Doss
9. Human Interactomics: Comparative Analysis of Different Protein Interaction Resources and
Construction of a Cancer Protein–Drug Bipartite Network
Javier De Las Rivas, Diego Alonso-López and Mónica M. Arroyo
Description
Protein-Protein Interactions in Human Disease, Volume 111, Part B, promotes further research and development in the protein interaction network in order to identify critical proteins involved in the etiology of human diseases and locate new protein targets for drug development. Thus, this volume is of considerable interest to protein chemists, pharmacologists, cell biologists, immunologists, structural biologists, computational biochemists and other researchers working in the field. In addition, these articles would be of great benefit to medical, biology and pharmacology students who specialize in this field.
Key Features
- Describes advances in the application of powerful techniques in studying and analyzing protein-protein interactions
- Ideal for a wide audience of researchers, specialists and students
- Written by authorities in their field
- Contains a number of high quality illustrations, figures and tables that support the presented information
Readership
Protein chemists, pharmacologists, cell biologists, immunologists, structural biologists, computational biochemists and other researchers working in this field. Articles published here would also be of great benefit to medical, biology and pharmacology students specializing in this field
Details
- No. of pages:
- 294
- Language:
- English
- Copyright:
- © Academic Press 2018
- Published:
- 17th February 2018
- Imprint:
- Academic Press
- Hardcover ISBN:
- 9780128143421
- eBook ISBN:
- 9780128143438
Ratings and Reviews
About the Serial Volume Editors
Rossen Donev Serial Volume Editor
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on design of antibody-based oral treatment of pathological conditions of the gastrointestinal tract.
Affiliations and Expertise
Swansea University, UK